Genome editing research targets late-onset Tay Sachs
Base editing has been used to correct the mutation causing late-onset Tay-Sachs disease in mice and human cells...
Base editing has been used to correct the mutation causing late-onset Tay-Sachs disease in mice and human cells...
Hundreds are set to receive the first-ever treatment licensed across Great Britain for a rare mitochondrial disease...
Dr Franklin Stahl, a prominent molecular biologist whose work helped solidify the DNA double helix model, has died aged 95...
by Dr Teja Rus
A precision genome-editing approach has successfully corrected harmful mutations in mitochondrial DNA, offering new hope for treating currently incurable mitochondrial diseases...
Genome editing has been used to disrupt a type of repetitive DNA sequence that is found in certain genes and can cause severe neurological disease...
A baby born with a rare genetic liver disease has received the world's first customised experimental treatment that involved directly repairing his DNA to fix a faulty protein...
Professor David Liu, the developer of base editing and prime editing, has won the Breakthrough Prize in Life Sciences, the largest annual monetary award in science...
A genome editing approach has been used to correct a disease-causing genetic variation in people, for the first time...
An artificial intelligence model has been developed that is capable of decoding genomes and designing synthetic DNA, RNA and proteins...
by Olivia Goff
A CRISPR genome-editing therapy has been shown for the first time to provide long-term genome correction in lung cells for treatment of cystic fibrosis in mice...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.